PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
13-Jul-2022 Gilead Sciences Appoints Deborah Telman as Executive Vice President, Corporate Affairs and General Counsel Gilead Sciences
13-Jul-2022 Original-Research: MagForce AG (von GBC AG) MagForce AG
13-Jul-2022 Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate Heidelberg Pharma AG
13-Jul-2022 Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU Relief Therapeutics Holding SA
13-Jul-2022 Gerresheimer AG: Gerresheimer on track to deliver record financial year 2022 after solid second quarter Gerresheimer AG
12-Jul-2022 IGEA Pharma N.V.: IGEA PHARMA HAS ANNOUNCED THAT LMH - AN INDUSTRIAL HOLDING COMPANY - HAS COMPLETED THE DUE DILIGENCE PROCESS FOR A EURO 6.000.000 COMMITTMENT TO FUND THE SWISS CBD EXTRACTION FACILIT IGEA Pharma N.V.
12-Jul-2022 ProBioGen Teams Up with Granite Bio for Cell Line Development and GMP Manufacturing Services B3C newswire
12-Jul-2022 Vaccentis appoints Martin Munte as CEO and strengthens Board Vaccentis
12-Jul-2022 Pivotal data demonstrate once-weekly efanesoctocog alfa provides superior bleed protection compared to prior factor prophylaxis Global Newswire
12-Jul-2022 Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitors Novo Nordisk
12-Jul-2022 No thromboembolic events or related serious adverse events reported over 12-week observation period in FRONTIER1 study. Novo Nordisk
12-Jul-2022 Neuraxpharm to increase branded business through upcoming acquisition of established products from Sanofi Neuraxpharm
12-Jul-2022 vasopharm GmbH Announces Brain Lactate Microdialysate Data from Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury vasopharm GmbH
12-Jul-2022 Destiny Pharma receives award from the Cystic Fibrosis Foundation Destiny Pharma
12-Jul-2022 Adrenomed appoints David Germonpré as Chief Financial Officer Adrenomed AG
12-Jul-2022 Connect in Pharma launches art exhibition and charity partnership to raise funds for rare disease research Sciad Newswire
12-Jul-2022 Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022 Heidelberg Pharma AG
12-Jul-2022 PolyPeptide Group provides market update PolyPeptide Group
11-Jul-2022 Accelerate Diagnostics Announces Commercialization in Europe of its Accelerate Arc™ System Having Completed IVDR Registration B3C newswire
08-Jul-2022 Weekly Pharma & Life Science News Round Up: 4th – 8th July PharmiWeb.Jobs